ArticleScience translational medicine2013

Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.

Ronald J Vagnozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.